Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease: Results from an Open-Label, Phase I Trial

被引：0

作者：

Muramatsu, Shin-Ichi ^{[1
]}

Fujimoto, Ken-Ichi ^{[1
]}

Kato, Seiya ^{[1
]}

Asari, Sayaka ^{[1
]}

Mizukami, Hiroaki ^{[1
]}

Ikeguchi, Kunihiko ^{[1
]}

Kawakami, Tadataka ^{[1
]}

Urabe, Masashi ^{[1
]}

Kume, Akihiro ^{[1
]}

Sato, Toshihiko ^{[2
]}

Watanabe, Eiju ^{[1
]}

Ozawa, Keiya ^{[1
]}

Nakano, Imaharu ^{[1
]}

机构：

[1] Jichi Med Univ, Shimotsuke, Japan

[2] Utsunomiya Cent Clin, Utsunomiya, Tochigi, Japan

来源：

MOLECULAR THERAPY | 2009年 / 17卷

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：S168 / S168

页数：1

共 50 条

[41] Gene Therapy Improves Cerebral White Matter Microstructures in Patients with Aromatic L-Amino Acid Decarboxylase Deficiency
Hwu, Wuh-Liang
Lee, Ni-Chung
Tseng, Chih-Hsien
Chien, Yin-Hsiu
Peng, Steven Shinn-Forng
Tseng, Wen-Yih Isaac
MOLECULAR THERAPY, 2018, 26 (05) : 31 - 31
[42] Eladocagene exuparvovec gene therapy improves motor development in patients with aromatic L-amino acid decarboxylase deficiency
Hwu, P.
Sierra, J.
Chien, Y-H
Lee, N-C
Wang, A.
Turna, J.
Penematsa, V
Golden, L.
Tai, C-H
ANNALS OF NEUROLOGY, 2023, 94 : S137 - S137
[43] Gene Therapy With Eladocagene Exuparvovec Improves Cognition and Language in Patients With Aromatic L-Amino Acid Decarboxylase Deficiency
Hwu, P.
Chien, Y.
Lee, N.
Tseng, S.
Wang, A.
Wang, J.
Schilling, T.
Ozdas, S.
Tai, C.
ANNALS OF NEUROLOGY, 2021, 90 : S98 - S99
[44] Eladocagene exuparvovec gene therapy improves motor development in patients with aromatic l-amino acid decarboxylase deficiency
Hwu, P. W-L
Chien, Y. H.
Lee, N. C.
Tseng, S. H.
Wang, A.
Wang, J.
Leonardi, E. T.
Schilling, T.
Ozdas, S.
Tai, C. H.
HUMAN GENE THERAPY, 2021, 32 (19-20) : A44 - A44
[45] Eladocagene Exuparvovec Gene Therapy Improves Motor Development in Patients With Aromatic L-Amino Acid Decarboxylase Deficiency
Russell, Alexis
Roubertie, Agathe
Chien, Yin-Hsiu
Lee, Ni-Chung
Sierra, Rafael
Turna, Jasmine
Wang, Antonia
Tai, Chun-Hwei
Hwu, Paul W-L
NEUROLOGY, 2023, 100 (17)
[46] ELADOCAGENE EXUPARVOVEC GENE THERAPY IMPROVES MOTOR DEVELOPMENT IN PATIENTS WITH AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY
Pachelli, P. E.
Giugliani, L.
Federhen, A.
Wang, A.
Russel, A.
Roubertie, A.
Chien, Y-H.
Lee, N-C.
Tai, C-H.
Wuh-Liang, P.
CYTOTHERAPY, 2022, 24 (10) : S5 - +
[47] Potential Therapeutic Approach Using Aromatic l-amino Acid Decarboxylase and Glial-derived Neurotrophic Factor Therapy Targeting Putamen in Parkinson's Disease
Tripathi, Raman Kumar
Goyal, Lav
Singh, Shamsher
CURRENT GENE THERAPY, 2024, 24 (04) : 278 - 291
[48] DISEASE BURDEN OF AROMATIC L-AMINO ACID DECARBOXYLASE (AADC) DEFICIENCY: SIGNS AND SYMPTOMS
Saberian, S.
Rowan, P.
Hammes, F.
Patel, P.
Fernandez-Cortes, F.
de Zarate, Beitia Ortiz, I
Buesch, K.
VALUE IN HEALTH, 2022, 25 (01) : S124 - S124
[49] Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
Eberling, J. L.
Jagust, W. J.
Christine, C. W.
Starr, P.
Larson, P.
Bankiewicz, K. S.
Aminoff, M. J.
NEUROLOGY, 2008, 70 (21) : 1980 - 1983
[50] AAV vector-mediated gene delivery of aromatic L-amino acid decarboxylase restored L-DOPA efficacy in a primate bilateral model of Parkinson's disease
Muramatsu, S
Ono, F
Nara, Y
Kodera, M
Takino, N
Tsuchida, J
Kawasaki, K
Ikeguchi, K
Fujimoto, K
Tsukada, H
Terao, K
Nakano, I
Ozawa, K
MOLECULAR THERAPY, 2004, 9 : S21 - S21

← 1 2 3 4 5 →